Answers are grounded in this paper and cite their sources.
Because NMDAR mediates long-term potentiation of memory However, currently no symptomatic treatment is available to enhance memory function in this disease. EphB2 receptors form a complex with NMDAR, and anti-NMDAR antibodies disrupt the cross-talk between NMDAR and EphB2 receptors Moreover, ephrin-B2 (the ligand of the EphB2 receptor) prevents intracellular internalization of NMDAR by disease antibodies Accordingly, some chemicals modulating the EphB2 receptor could affect NMDAR encephalitis symptoms; however, no clinically usable drugs have been approved for this purpose. Because memory loss is largely reversible after remission of the disease, education regarding the disease course and psychological support for family members are necessary.
No takes yet. Share an insight, caveat, or question.
Soon‐Tae Lee (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: